Journal: eNeuro
Article Title: Transient Receptor Potential Channels TRPM4 and TRPC3 Critically Contribute to Respiratory Motor Pattern Formation but not Rhythmogenesis in Rodent Brainstem Circuits
doi: 10.1523/ENEURO.0332-17.2018
Figure Lengend Snippet: Time-dependent changes in the amplitude of integrated XII inspiratory burst activities (XII Amp) and the field GCaMP6f fluorescence transients (Δ F ) of the pre-BötC glutamatergic population after TRPM4, TRPC3, and I CAN inhibitors. A , Control experiments ( n = 5 mice) to test for possible photobleaching and time-dependent changes in population activity, in which calcium imaging was performed without any drug application with exactly the same protocol of image acquisition as the pharmacological experiments. The results (mean normalized values ± SEM) show that there were no significant changes in the pre-BötC field Δ F amplitude, XII Amp (normalized to control values), and normalized inspiratory burst frequency ( f R ). B , Group summary data (mean normalized values ± SEM) for 9-phenanthrol, Pyr3, and FFA ( n = 5, 5, and 4, respectively) shows reduction in both XII Amp and the pre-BötC field Δ F amplitude, while f R changed nonsignificantly after applying channel inhibitors in all cases. C , Time-dependent reductions of XII Amp and field Δ F amplitudes after drug application were positively correlated (solid lines: linear regression; Pearson linear correlation coefficient for 9-phenanthrol, Pyr3, and FFA: r = 0.864, 0.845, and 0.749, respectively). The linear regression on mean amplitude reduction between XII Amp and field Δ F for 9-phenanthrol, Pyr3, and FFA yielded corresponding linear models with slopes m = 0.859, 0.463, and 0.676, and intercepts b = 0.103, 0.499, and 0.277, respectively. Dashed lines represent the identity line.
Article Snippet: We analyzed the time course of perturbations of the inspiratory burst frequency, amplitude, and duration of integrated XII inspiratory motor output after application to the slice bathing solution of the putative selective TRPM4 channel inhibitor (9-phenanthrol, Millipore, 10–50 μ m ; ), the selective TRPC3 channel inhibitor (Pyrazole compound-3: Pyr3, Millipore, 10–50 μ m ; ), and for comparison, the putative I CAN blocker flufenamic acid (FFA, Sigma-Aldrich, 20–75 μ m ; ; ).
Techniques: Fluorescence, Control, Activity Assay, Imaging